Skip to main content
Tech.euFundingExplorerBeta

Metabomed

Drug discovery company in the field of cancer metabolism

Yavne, IsraelFounded 2014www.ms-ventures.com/en/portfolio.html ↗
Healthtech
← All companies
Total raised
€16M
€16,363,636
Funding rounds
1
Investors
5
distinct backers
Active since
2016-03
latest 2016-03

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood16
base rate 44% for Series A
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2016-04-01Series A€16MArkin Holdings,Boehringer Ingelheim Venture Fund,MS Ventures,Pfizer,Pontifax FundsView deal →

Investors

5
Arkin HoldingsBoehringer Ingelheim Venture FundMS VenturesPfizerPontifax Funds

Similar companies

same sector or country